Amgen, Sanofi back a round for real-world evidence platform tech; Daiichi Sankyo's pexidartinib secures speedy FDA review
→ Aetion has garnered $27 million from a new venture round that includes some of the biggest names in healthcare. The company plans to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
